Work

Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk, first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimen

Year: 2024

Type: article

Abstract: Not available.

Source: Haematologica

DOI: 10.3324/haematol.2024.285837

Authors: Christina Peters, Angela Bruno, Carmelo Rizzari, Alessandra Brescianini, Arend Von Stackelberg, Christin Linderkamp, Yi Zeng, Gerhard Zugmaier, Franco Locatelli

Institutions: University of Vienna, St Anna Children's Hospital, St. Anna Children's Cancer Research Institute, University of Milano-Bicocca, Charité - Universitätsmedizin Berlin, Medizinische Hochschule Hannover, Amgen (United States), Amgen (Germany), Università Cattolica del Sacro Cuore, Bambino Gesù Children's Hospital

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

Funder: Amgen

OpenAlex ID: W4402262590

FWCI: 1.152

Cites:

Cited by: 3

Related to: 10